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Abstract; 
Background; Hypertension remains an important risk factor which contributes towards the worsening of the 
outcomes, consisting of cardio-renal anemia syndrome and its impact in heart failure remains to be complex and 
multifactorial. The current study was done to evaluate the role of hypertension on mortality among patients 
having congestive heart failure. Material and methods; This study included a total of 115 patients with 
congestive heart failure presenting at Nishtar Hospital Multan. These patients were followed till discharge to 
document in-hospital mortality during current hospitalization. All the sociodemographic distribution and other 
relevant information such as age, gender, area of residence, diabetes, hypertension,  obesity, smoking, 
hyperlipidemia and mortality were noted in the proforma and data was entered and analyzed by SPSS version 22 
for descriptive statistics and tests of significance. hypertension was cross-tabulated against in-hospital mortality 
using two by two table and chi-square test was applied at level of significance of 0.05. Results; Among our 115 
patients with congestive heart failure, 75 (65.2%) were males and 40 (34.8%) were females. Mean age of our 
patients with CHF was 57.17 ± 11.65 years ranging from 34 to 80 years. Although males were younger than 
female patients with congestive heart failure but this difference was not statistically significant (p=0.140). 
Seventy five (65.2%) were from rural areas, 40 (34.8%) were poor, 70 (60.9%) from middle income families and 
only 5 (4.3%) belonged to rich families. Mean body mass index (BMI) of patients with congestive heart failure 
was 26.12 ± 2.93 kg/m2 and 35 (30.4%) were obese. Twenty five (21.7%) were smokers. Forty five (39.1%) had 
diabetes and 55 (47.8%) had hypertension. In-hospital mortality in patients with congestive heart failure was 12 
(10.4%) and of these 12 mortalities, hypertension was noted in 11 (92 %) patients. Conclusion; Our study 
results have documented high frequency of hypertension among patients with congestive heart failure and 
hypertension was significantly associated with in – hospital mortality.  
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Introduction; 
Cardiovascular diseases are the leading cause of mortality all over the world 1-3, particularly in developing 
countries as the mortality rates among developed nations have dropped down significantly due to the availability 
of the healthcare facilities and advancements in techniques owing to patient care 4-5. Heart failure is associated 
with significant medical, financial, psychological and societal burden with high rates of emergency department 
admissions6. In USA, due to the heart failure (as a primary or secondary diagnosis), approximately more than 2.6 
million patients get hospitalized every year and increase cost of healthcare budget enormously 7. Congestive 
heart failure is a common health issue with high rates of mortality, emergency department/hospital admissions, 
reduced physical activity, poor productivity, loss of work and poor quality of life of the patients 8-10. There are 
other modifiable as well as non-modifiable factors which lead to the worsening of the conditions of the patient 
and poor prognosis in addition to direct impact of congestive heart failure 11-13. Anemia is also a major cause of 
disease morbidity, poor quality of life and productivity, reduced physical activity and is common entity among 
heart failure patients, hence representing a modifiable risk factor for poor prognosis and adverse clinical 
outcomes. It is also a strong predictor for the burden of related co-morbidities and for increased severity of the 
disease.  
Hypertension remains an important risk factor which contributes towards the worsening of the outcomes, 
consisting of cardio-renal anemia syndrome and its impact in heart failure remains to be complex and 
multifactorial 13-15.  
Owing to role of hypertension in congestive heart failure in worsening of the condition and poor prognosis of the 
patients, this study was conducted to evaluate role of hypertension in CHF in Southern Punjab. This study was 
done to determine the role of hypertension associated with mortality to generate evidence on this topic as there is 
limited data on this topic from Pakistan.  
Material and methods;  
This study included a total of 115 patients with congestive heart failure presenting at Nishtar Hospital, Multan. 
Congestive Heart failure patients more than 20 years of age were included and CHF was defined as “patients 
having shortness of breath having Killip class I-IV (class I=no cracles, class II=JVP, class III=pulmonary edema, 
class IV=cardiogenic shock) and swelling of legs (assessed on clinical judgment by 2-3 minutes pressing of 
medial malleolus, if pit develops it was taken as positive) for more than 1 month (presence of all) which is 
consistent with echocardiographic findings (percentage of blood ejected with each beat – less than 50 – 75%” 
while patients having any malignancy, chronic obstructive pulmonary disease, poor intake and CABG were 
excluded. These patients were followed till discharge to document in-hospital mortality during current 
hospitalization. All the sociodemographic distribution and other relevant information such as age, gender, area of 
residence, diabetes, hypertension,  obesity, smoking, hyperlipidemia and mortality were noted in the proforma 
and data was entered and analyzed by SPSS version 22 for descriptive statistics and tests of significance. Anemia 
was cross-tabulated against in-hospital mortality using two by two table and chi-square test was applied at level 
of significance of 0.05.  
Results; 
Among our 115 patients with congestive heart failure, 75 (65.2%) were males and 40 (34.8%) were 
females. Mean age of our patients with CHF was 57.17 ± 11.65 years ranging from 34 to 80 years. Although 
males were younger than female patients with congestive heart failure but this difference was not statistically 
significant (p=0.140). Seventy five (65.2%) were from rural areas, 40 (34.8%) were poor, 70 (60.9%) from 
middle income families and only 5 (4.3%) belonged to rich families. Mean body mass index (BMI) of patients 
with congestive heart failure was 26.12 ± 2.93 kg/m2 and 35 (30.4%) were obese. Twenty five (21.7%) were 
smokers. Mean hemoglobin level of these patients was 11.36 ± 2.55 d/dl ranging from 6.6 to 14.7 g/dl and 
anemia was documented in 60 (52.2%) our patients. Forty five (39.1%) had diabetes and 55 (47.8%) had 
hypertension. In-hospital mortality in patients with congestive heart failure was 12 (10.4%) and of these 12 
mortalities, hypertension was noted in 11 (92 %%) patients (p = 0.005).  
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Discussion; 
Hypertension remains an important risk factor which contributes towards the worsening of the 
outcomes, consisting of cardio-renal anemia syndrome and its impact in heart failure remains to be complex and 
multifactorial 16-17. Among our 115 patients with congestive heart failure, 75 (65.2%) were males and 40 (34.8%) 
were females. Silverberg et al 18 documented 79 % male patients having congestive heart failure, in compliance 
with our study results. Dai et al 19 has also reported similar results. Rasheed et al 20 reported 88% male patients 
with congestive heart failure showing compliance with our findings. Khan et al 21 reported 60 % male gender 
predominance in patients with CHF which are close to our study results. Nasir et al 22 reported male gender 
preponderance with 65 % which is close to our study results. 
Mean age of our patients with CHF was 57.17 ± 11.65 years ranging from 34 to 80 years. Although males were 
younger than female patients with congestive heart failure but this difference was not statistically significant 
(p=0.140). Rasheed et al 20 reported 50.77 ± 7.53 years mean age which is close to our study results. Nasir et al 22 
reported 60 ± 13 years mean age which is similar to that of our study results. Vim et al 23 from Iran also reported 
61 years mean age of the patients with congestive heart failure (CHF) which is close to our study results. 
Mean body mass index (BMI) of patients with congestive heart failure was 26.12 ± 2.93 kg/m2 and 35 
(30.4%) were obese. Twenty five (21.7%) were smokers. Forty five (39.1%) had diabetes and 55 (47.8%) had 
hypertension and hypertension was significantly associated with in – hospital mortality (p = 0.005). Silverberg et 
al 18 reported diabetes in 30 %, hypertension in 64% and smoking in 40 % patients. These findings are close to 
our study results. Dai et al 19 reported similar results. 
Conclusion; 
 Our study results have documented high frequency of hypertension among patients with congestive heart 
failure. In-hospital mortality was significantly associated with hypertension.   
References; 
1. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: 
Statistics from World Health Organisation and United Nations. Int J Cardiol. 2013;168(2):934–45. 
2. Nowbar AN, Howard JP, Finegold JA, Asaria P, Francis DP.  2014 global geographic analysis of 
mortality from ischaemic heart disease by country, age and income: statistics from World Health 
Organisation and United Nations. Int J Cardiol. 2014;174(2):293-8.  
3. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, et al. Temporal trends in 
ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 
study. Circulation. 2014;129(14):1483-92.  
4. Zhu KF, Wang YM, Zhu JZ, Zhou QY, Wang NF. National prevalence of coronary heart disease and its 
relationship with human development index: A systematic review. Eur J Prev Cardiol. 2016 
Mar;23(5):530-43.  
5. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of 
global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a 
systematic review and analysis. Lancet. 2013 Oct 19;382(9901):1329-40.  
6. Prado-Galbarro FJ, Del-Cura-González I, Garrido-Elustondo S, Gamiño-Arroyo AE, Sánchez-Piedra C, 
Sarriá Santamera A. A Comparison of Methods for Modeling Factors Associated with Hospital 
Admissions in Incident Cases of Heart Failure. Rev Esp Salud Publica. 2017 May 24;91. pii: 
e201705034. 
7. Alexandrakis MG, Tsirakis G. Anemia in Heart Failure Patients. ISRN Hematol. 2012;ID 246915. 
http://dx.doi.org/10.5402/2012/246915 
8. Badreddin A, Fady Y, Attia H, Hafez M, Khairallah A, Johar D, et al. What role does the stress 
response have in congestive heart failure? J Cell Physiol. 2017 May 11. doi: 10.1002/jcp.26003.  
9. Marenzi G, Muratori M, Cosentino ER, Rinaldi ER, Donghi V, Milazzo V, et al. Continuous 
ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail. 2014 May;20(5):378.e1-9. 
10. Canaud B1, Bowry SK, Tetta C, Gatti E. The case for treating refractory congestive heart failure with 
ultrafiltration. Blood Purif. 2014;37 Suppl 2:51-60.  
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal DOI: 10.7176/JMPB 
Vol.55, 2019 
 
28 
11. Khan M, Jehangir W, Daood MS, Khan A, Mallick NH. Frequency of anemia and renal insufficiency in 
patients with heart failure. J Ayub Med Coll Abbottabad. 2010;22(3):87-9. 
12. Charlot M, Torp-Pedersen C, Valeur N, Seibæk M, Weeke P, Køber L. Anaemia and long term 
mortality in heart failure patients: a retrospective study. Open Cardiovasc Med J. 2010;4:173-7.  
13. Sandhu A, Soman S, Hudson M, Besarab A. Managing anemia in patients with chronic heart failure: 
what do we know? Vasc Health Risk Manag. 2010 Apr 15;6:237-52. 
14. Kilicgidik A, Dundar C, Tigen MK. Anemia in heart failure. Anadolu Kardiyol Derg.  2012;12:65-70. 
15. Oster HS, Benderly M, Hoffman M, Cohen E, Shotan A, Mittelman M. Mortality in heart failure with 
worsening anemia: a national study. Isr Med Assoc J. 2013;15(7):368-72. 
16. Pongsuthana S, Tanghongse V. Correlation of anemia and clinical outcomes in heart failure at Rajavithi 
Hospital. J Med Assoc Thai. 2014;97:41-7. 
17. Kuule JK, Seremba E, Freers J. Anaemia among patients with congestive cardiac failure in Uganda - its 
impact on treatment outcomes. S Afr Med J. 2009;99(12):876-80. 
18. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous 
erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart 
failure improves cardiac and renal function and functional cardiac class, and markedly reduces 
hospitalizations. J Am Coll Cardiol. 2000 Jun;35(7):1737-44. 
19. Dai Y, Konishi H, Takagi A, Miyauchi K, Daida H. Red cell distribution width predicts short- and long-
term outcomes of acute congestive heart failure more effectively than hemoglobin. Exp Ther Med. 2014 
Aug;8(2):600-606. 
20. Rasheed SZ, Samad A. Exercise Stress Test early after acute Myocardial Infarction: predictive value for 
subsequent development of Congestive Cardiac Failure. Pak J Cardiol. 1999;10(2-3):41-6.  
21. Khan Z, Khan B, Hiader I, Khan I, Din J, Khan H, et al. Etiology of congestive heart failure at a tertiary 
care hospital. Rawal Med J. 2010;35(2):141-4.  
22. Nasir U, Shahid H, Shabbir MO. Sleep quality and depression in hospitalized congestive heart failure 
patients. J Pak Med Assoc. 2015;65(3):264-9. 
23. Vim S, Ahmadi H. Factors influencing the length of hospital stay of patients with heart failure. Pak J 
Cardiol. 2005;16(1):29-34. 
 
 
 
